Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy

Drug Alcohol Rev. 2008 Jan;27(1):1-3. doi: 10.1080/09595230701711157.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Australia / epidemiology
  • Drug Implants
  • Ethics, Medical
  • Humans
  • Legislation, Medical
  • Naltrexone* / administration & dosage
  • Naltrexone* / adverse effects
  • Naltrexone* / therapeutic use
  • Narcotic Antagonists* / administration & dosage
  • Narcotic Antagonists* / adverse effects
  • Narcotic Antagonists* / therapeutic use
  • Opioid-Related Disorders / drug therapy*
  • Opioid-Related Disorders / metabolism

Substances

  • Drug Implants
  • Narcotic Antagonists
  • Naltrexone